FR2100936A1 - Injectable narcotic antagonist - formulation with long duration of action - Google Patents

Injectable narcotic antagonist - formulation with long duration of action

Info

Publication number
FR2100936A1
FR2100936A1 FR7126507A FR7126507A FR2100936A1 FR 2100936 A1 FR2100936 A1 FR 2100936A1 FR 7126507 A FR7126507 A FR 7126507A FR 7126507 A FR7126507 A FR 7126507A FR 2100936 A1 FR2100936 A1 FR 2100936A1
Authority
FR
France
Prior art keywords
action
pamoate
long duration
formulation
hydroxynormorphinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7126507A
Other languages
English (en)
French (fr)
Other versions
FR2100936B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENDO LAB
Original Assignee
ENDO LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENDO LAB filed Critical ENDO LAB
Publication of FR2100936A1 publication Critical patent/FR2100936A1/fr
Application granted granted Critical
Publication of FR2100936B1 publication Critical patent/FR2100936B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7126507A 1970-07-21 1971-07-20 Injectable narcotic antagonist - formulation with long duration of action Granted FR2100936A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5697570A 1970-07-21 1970-07-21
US12033671A 1971-03-02 1971-03-02

Publications (2)

Publication Number Publication Date
FR2100936A1 true FR2100936A1 (en) 1972-03-24
FR2100936B1 FR2100936B1 (enrdf_load_stackoverflow) 1974-09-06

Family

ID=26735916

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7126507A Granted FR2100936A1 (en) 1970-07-21 1971-07-20 Injectable narcotic antagonist - formulation with long duration of action

Country Status (3)

Country Link
CA (1) CA964192A (enrdf_load_stackoverflow)
DE (1) DE2135856A1 (enrdf_load_stackoverflow)
FR (1) FR2100936A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472501A3 (en) * 1990-08-23 1993-02-24 Ciba-Geigy Ag Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6614309A (enrdf_load_stackoverflow) * 1962-06-29 1966-12-27

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6614309A (enrdf_load_stackoverflow) * 1962-06-29 1966-12-27

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472501A3 (en) * 1990-08-23 1993-02-24 Ciba-Geigy Ag Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations

Also Published As

Publication number Publication date
DE2135856A1 (enrdf_load_stackoverflow) 1972-01-27
CA964192A (en) 1975-03-11
FR2100936B1 (enrdf_load_stackoverflow) 1974-09-06

Similar Documents

Publication Publication Date Title
CA918937A (en) Combustion chamber clustering structure
AU3636071A (en) Medicament injectors
ZA869586B (en) Pharmaceutical product for the sustained release of ibuprofen
CA928134A (en) Feed intake limiting composition for cattle
Eksborg et al. Drug level monitoring: cytostatics
FR2100936A1 (en) Injectable narcotic antagonist - formulation with long duration of action
CA943813A (en) Pump having rotor with transverse feed and discharge
AU454533B2 (en) Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof
CA934780A (en) Structure for and method of sorting and orienting
CA956526A (en) Tool for administering injections to livestock
MY7800121A (en) 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17 (alpha)-pregn-4-ene-21-carboxylic acid y-lactones and congeners
CA935450A (en) Portable ring storage and feeding unit
Larsen et al. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice
MORII et al. Effect of Sympathetic Stimulation, Epinephrine and Phentolamine on Recovery from Induced Hypocalcemia
SU589987A1 (ru) Способ повышени устойчивости организма к возникновению опухолей
AU3470471A (en) Improvements in and relating to seating unit
Ison Stereochemical studies of antihistaminic agents
DUDEK Performance, recovery and man machine effectiveness(Determination of optimal work-rest cycle for individuals and crews to yield high performance in man machine effectiveness)[Semiannual Progress Report, 1 Mar.- 31 Aug. 1971]
MALKIN et al. Efficacy of conditioning animals to hypoxia during sleep
Vyazovskaya et al. The relationship between the concentrations of thyrotropic hormone in the hypophysis and the peripheral blood
AU2334070A (en) Improvements relating to lick feeders
AU3489471A (en) Improvements in and relating to cane harvesters
ZA717374B (en) Improvements relating to seating and beds
CA850800A (en) Threshold analyzer for an implanted heart stimulator
CA834791A (en) Treatment of coal and other minerals

Legal Events

Date Code Title Description
ST Notification of lapse